Daily News

April 30, 2020

• Mitsubishi Tanabe Drops Seasonal Flu Vaccine Project in US, Canadian Plan Intact
  April 30, 2020

• Wakamoto, Rohto Forge Comprehensive Biz Tie-Up
  April 30, 2020

• Shionogi’s Novel Antibiotic Cefiderocol Approved in Europe
  April 30, 2020

• Astellas, Harvard Seal 3-Year Research Alliance Pact
  April 30, 2020

• Chugai Plans May Enrollment Start for Actemra COVID-19 Trial, Aims for Approval by Year-End
  April 30, 2020

• Mitsuka to Bow Out from Mitsubishi Tanabe Board
  April 30, 2020

• Bayer Japan Ethical Drug Sales Grow 4.2% in 2019
  April 30, 2020

• Sanofi Japan to Ensure Drug Supplies, Employees’ Safety at the Same Time in COVID-19 Crisis: Chief
  April 30, 2020

• PhRMA, EFPIA Issue Joint Statement on Air Transporting Critical Medicines amid COVID-19 Outbreak
  April 30, 2020

• AZ to Divest 4 Off-Patent Drugs to Taiyo Pharma
  April 30, 2020

• Japan Can’t Give “Special Approval” for Avigan under Current Law: Abe
  April 30, 2020

• Japan to Quickly Utilize “Special Approval” Scheme for Remdesivir after It’s OK’ed Overseas: Minister
  April 30, 2020

• JMA Calls for Early Avigan Use in High-Risk Patients Hospitalized with COVID-19
  April 30, 2020

• Lilly’s 3 Tadalafil Products Transferred to Nippon Shinyaku
  April 30, 2020

• Sumitomo Dainippon Ups FY2019 Guidance on Brisk North America, Japan Biz
  April 30, 2020

• Takeda’s Mobocertinib Bags FDA Breakthrough Therapy Status for EGFR Exon 20 Mutant NSCLC
  April 30, 2020